Pharmaceutical Filtration Devices Market Soar to Reach $23 Billion in the Revenue with Noteworthy Players by 2022: Growth Factors & Trends

Pharmaceutical Filtration Devices Market
Pharmaceutical Filtration Devices Market report, published by Market Research Future contains succinct information on to provide country level analysis of the market with respect to the current market size and future prospective for segments by type, by application, by end user and its sub-segments.

Pharmaceutical Filtration Devices Market – Competitive Analysis

Characterized by the presence of several well-established and small players, the Global Pharmaceutical Filtration Devices Market appears to be highly competitive and fragmented. International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing.  The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2432

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

In September, 2016- GE Healthcare acquired Biosafe Group and introduced Sefia, a state-of-the-art, multi-function platform which uses a combination of continuous-flow centrifugation, temperature control and fluidic management to enable purification, concentration, washing and final formulation during cell processing. Combined with GE Healthcare’s existing portfolio, Sefia further advances access to a single-solution manufacturing platform to enable turnkey, scalable manufacturing of cell therapies.

In May, 2015- Danaher Corporation announced today that the company entered into a definitive merger agreement with Pall Corporation pursuant to which Danaher acquired all of the outstanding shares of Pall for USD 127.20 per share in cash, i.e., for a total enterprise value of approximately USD 13.8 billion, including assumed debt and net of acquired cash. 

In February, 2017- Parker Hannifin Corporation, completed the acquisition of CLARCOR Inc., a major manufacturer of filtration products, for approximately USD 4.3 billion in cash which included the assumption of net debt. The strategic transaction created a combined organization with a comprehensive portfolio of filtration products and technologies, offering customers a single streamlined source for all their purification and separation needs.

In April, 2017- Sartorius Stedim Biotech acquired the Umetrics business (from the U.S. based MKS Instruments Group. Umetrics is a highly specialized, globally leading provider of data analytics software for modelling and optimizing development and manufacturing processes. SSB has been a cooperation partner of Umetrics since the end of 2012, distributing and co-marketing their software to major players in the biopharmaceutical industry.

Pharmaceutical Filtrations Devices Market – Highlights

The Global Pharmaceutical Filtration Devices Market is growing with the sound pace. According to a recent study report published by the Market Research Future, the Global Pharmaceutical Filtration Devices Market is booming and expected to gain prominence over the forecast period growing. The market is forecasted to demonstrate a sound growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2022)

Filtration is used in pharmaceutical industry to purify and separate the component of therapeutic application. Additionally, the process can be used to maintain sterile conditions of processing and prevent contamination of the therapeutic entities. Various methods of filtration like air filtration, water filtration, chemical filtrations, and grade filtration are being used for filtration in the pharmaceutical industry. Factors such as growing biotechnology and pharmaceutical sector and rising healthcare expenditure are the major drivers for the market growth during the forecast period.

The U.S. is the largest market for biopharmaceuticals and accounts for one third of the global market. Moreover, it is estimated that the U.S. biopharmaceutical sector accounts for around 17% of all domestic R&D funded by the U.S. businesses and added an estimated USD 1.2 trillion in economic output of 2014. Additionally, rising global burden of the diseases and increasing demands for healthcare services boosts the market. However, huge capital cost for setting up new production facilities followed by stringent government regulations are estimated to restrain the market growth during the forecast period.

Pharmaceutical Filtrations Devices Market – Key Players

Some of the key players in this market are: GE Healthcare (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech S.A. (France), Merck KGaA (Germany), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), and GEA Group (Germany).

Pharmaceutical Filtrations Devices Market – Regional Analysis

Considering the global scenario of the market, Americas region is believed to be the largest market for Pharmaceutical filtration techniques and devices. Moreover the European market is also growing continuously and slowly catching up with the American market. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the pharmaceutical filtration devices segment during the forecasted period. Middle East & Africa region are likely to have a limited but steady growth in the market.

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/2432

Pharmaceutical Filtrations Devices Market – Segments

The pharmaceutical filtrations market has been segmented on the basis of type of filtrations, product, and their application in pharmaceutical industry. On the basis of type the market has been segmented as air filtration, water filtration, chemical filtrations, Grade filtration (liquid and gas), and absorptive filtrations. Similarly on the basis of product, the market has been segmented into membrane filters, media filters, cartridges and capsule filtration and others. On the basis of application in pharmaceutical industry the filtrations market has again segment into air purification, water purification, sterilization, cell separation, media and buffer filtrations and others.

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued….

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com